Primary immune thrombocytopenia complicated with perioperative deep
venous thrombosis: a case report and literature review

doi:10.3760/cma.j.issn.1007-1245.2022.11.026

Abstract

Abstract: Objective　To explore the clinical scheme in prevention of bleeding and thrombosis in perioperative patients with primary immune thrombocytopenia (ITP). Methods　The clinical data of a patient with ITP and deep venous thrombosis during perioperative period were analyzed retrospectively, and the relevant literatures were summarized and reviewed. Results　ITP patients should pay attention not only to the risk of thrombocytopenia related bleeding, but also to the risk of thrombotic events. Surgery and platelet raising therapy may be the risk factors of thrombosis in patients with ITP. During the perioperative period, it is recommended to routinely monitor blood routine, coagulation function, and vascular ultrasound, stop platelet raising drugs in time, and take anticoagulant treatment if it is necessary, so as to prevent and early detect deep venous thrombosis. Conclusion　Patients with ITP should be alert to the risk of thrombosis during perioperative period.

Key words: Primary immune thrombocytopenia, Thrombosis, Perioperative Period

摘要： 目的　探讨围术期合并原发免疫性血小板减少症（ITP）病例预防出血及血栓形成的临床应对方案。方法　回顾性分析1例ITP患者并发围术期深静脉血栓的临床资料，并汇总复习相关文献资料。结果　ITP患者不仅需关注血小板减少相关出血风险，也应当关注发生血栓事件风险。手术及升血小板治疗均有可能是ITP患者血栓发生的危险因素。围术期建议常规监测血常规、凝血功能及血管超声检查，适时停用升血小板药物，必要时需抗凝治疗，以预防及早期发现深静脉血栓。结论　围术期的ITP患者需警惕血栓发生风险。

关键词: 原发免疫性血小板减少症, 血栓, 围术期

Chang Jing, Sun Aichun. Primary immune thrombocytopenia complicated with perioperative deep venous thrombosis: a case report and literature review[J]. International Medicine and Health Guidance News, 2022, 28(11): 1592-1594.

常婧, 孙爱春. 原发免疫性血小板减少症并发围术期深静脉血栓1例并文献复习及思考[J]. 国际医药卫生导报, 2022, 28(11): 1592-1594.

References

[1] Berchtold P, Wenger M. Autoantibodies against platelet glycoproteins in autoimmune thrombocytopenic purpura: their clinical significance and response to treatment[J]. Blood, 1993,81(5):1246-1250. DOI: 10.1182/blood.V81.5.1246.1246.

[2] McMillan R, Wang L, Tomer A, et al. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP[J]. Blood, 2004,103(4):1364-1369. DOI: 10.1182/blood- 2003- 08-2672.

[3] 中华医学会血液学分会血栓与止血学组.成人原发免疫性血小板减少症诊断与治疗中国指南(2020年版)[J].中华血液学杂志,2020,41(8):617-623.DOI:10.3760/cma.j.issn.0253-2727.2020.08.001.

[4] Matzdorff A, Beer JH. Immune thrombocytopenia patients requiring anticoagulation--maneuvering between Scylla and Charybdis[J]. Semin Hematol, 2013,50 Suppl 1:S83-88. DOI: 10.1053/j.seminhematol.2013.03.020.

[5] Haque S, Dinh A, Rathi N, et al. Thrombocytopenia does not protect from deep vein thrombosis in critically ill cancer patients[J].Chest,2011;140(4):878A.DOI:10.1378/chest.1119773.

[6] Rodeghiero F. Is ITP a thrombophilic disorder?[J]. Am J Hematol, 2016,91(1):39-45. DOI: 10.1002/ajh.24234.

[7] Sarpatwari A, Bennett D, Logie JW, et al. Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database[J]. Haematologica,2010,95(7):1167-1175.DOI:10.3324/haematol.2009.018390.

[8] Enger C, Bennett D, Forssen U, et al. Comorbidities in patients with persistent or chronic immune thrombocytopenia[J].Int J Hematol,2010,92(2):289-295.DOI: 10.1007/s12185-010-0636-3.

[9] Severinsen MT, Engebjerg MC, Farkas DK, et al. Risk of venous thromboembolism in patients with primary chronic immune thrombocytopenia: a danish population- based cohort study[J].Br J Haematol,2011,152(3):360-362.DOI:10.1111/j.1365-2141.2010.08418.x.

[10] Nørgaard M, Severinsen MT, Lund Maegbaek M, et al. Risk of arterial thrombosis in patients with primary chronic immune thrombocytopenia: a Danish population- based cohort study[J].Br J Haematol,2012,159(1):109-111.DOI:10.1111/j.1365-2141.2012.09231.x.

[11] 黄月婷,刘晓帆,陈云飞,等.原发免疫性血小板减少症患者血栓发生情况及相关危险因素分析[J].中华血液学杂志,2018,39(11):942-946.DOI:10.3760/cma.j.issn.0253- 2727. 2018.11.014.

[12] Sewify EM, Sayed D, Abdel Aal RF, et al. Increased circulating red cell microparticles (RMP) and platelet microparticles (PMP) in immune thrombocytopenic purpura[J]. Thromb Res, 2013,131(2):e59-63. DOI: 10.1016/j.thromres.2012.11.021.

[13] Flaumenhaft R. Formation and fate of platelet microparticles[J]. Blood Cells Mol Dis, 2006,36(2):182-187. DOI: 10.1016/j.bcmd.2005.12.019.

[14] Kim WH, Park JB, Jung CW, et al. Rebalanced hemostasis in patients with idiopathic thrombocytopenic purpura[J]. Platelets, 2015,26(1):38-42. DOI: 10.3109/09537104. 2013.869312.

[15] Heit JA, Silverstein MD, Mohr DN, et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study[J]. Arch Intern Med, 2000,160(6):809-815. DOI: 10.1001/archinte.160.6.809.

[16] 中华医学会血液学分会血栓与止血学组.成人原发免疫性血小板减少症诊断与治疗中国专家共识(2012年版)[J].中华血液学杂志,2012,33(11):975-977.DOI:10.3760/cma.j.issn.0253-2727.2012.11.021.

[17] Provan D, Arnold DM, Bussel JB, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia[J]. Blood Adv, 2019,3(22):3780-3817. DOI: 10.1182/bloodadvances.2019000812.

[18] 郝杰,王黎,王艳煜,等.地西他滨联合DAG方案等三种方案治疗复发、难治急性髓系白血病疗效的比较分析[J].中华血液学杂志,2014,35(6):481-485.DOI:10.3760/cma.j.issn.0253-2727.2014.06.001.

[19] 张琳,王琳,石艳,等.原发免疫性血小板减少症合并血栓形成的危险因素分析[J].临床血液学杂志,2017,30(9):693-696,700.DOI:10.13201/j.issn.1004-2806. 2017. 09.009.

[20] 中华医学会外科学分会.中国普通外科围手术期血栓预防与管理指南[J/CD].消化肿瘤杂志(电子版),2016,8(2):57-62.DOI:10.3969/j.issn.1674-7402.2016.02.004.

Primary immune thrombocytopenia complicated with perioperative deep venous thrombosis: a case report and literature review

原发免疫性血小板减少症并发围术期深静脉血栓1例并文献复习及思考

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 6

Recommended Articles

Metrics

[1]	Ke Mingchi, Hu Dong, Zhu Fajun, Chen Hui, Wu Xinmiao. Effect of perioperative intervention measures based on thromboelastogram for elderly patients with femoral neck fracture [J]. International Medicine and Health Guidance News, 2022, 28(9): 1239-1242.
[2]	Song Dan. Analysis of risk factors of deep venous thrombosis in ≥60 years old inpatients undergoing PICC catheterization [J]. International Medicine and Health Guidance News, 2022, 28(4): 552-555.
[3]	Zhou Yexiu, Wei Renjie, Huang Dabo, Wei Jiehe, Wei Liyong, Huang Juanjuan, Lan Wanjie. Effect of diagnosis and treatment pathways based on enhanced recovery after surgery for patients with ankle fracture during perioperative period [J]. International Medicine and Health Guidance News, 2022, 28(3): 345-348.
[4]	Hong Gengde, Fang Nan, Deng Ying, Gao Ling, Chen Dongping, Huang Yufang. Perioperative application of immune nutrition in patients with esophageal neoplasms [J]. International Medicine and Health Guidance News, 2022, 28(3): 439-444.
[5]	Dou Shoukun, Xia Guili, Liu Zeqin, Wan Xin, Zhang Jing, Cheng Qing. Effects of ball grip exercise intensities of different metabolic equivalents on catheter complications and exercise fatigue after PICC catheterization [J]. International Medicine and Health Guidance News, 2022, 28(12): 1734-1739.
[6]	Chen Xiuxiao, Sui Wenqian, Wu Yuanyuan. A case of acute superior mesenteric venous thrombosis diagnosed by emergency ultrasonography [J]. International Medicine and Health Guidance News, 2022, 28(10): 1438-1439.